Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) rose 12% during mid-day trading on Friday . The company traded as high as GBX 9.40 ($0.12) and last traded at GBX 9.38 ($0.12). Approximately 303,166 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 259,928 shares. The stock had previously closed at GBX 8.38 ($0.11).
Ondine Biomedical Trading Up 12.0 %
The firm has a 50-day moving average of GBX 6.69 and a 200 day moving average of GBX 7.20. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37. The stock has a market capitalization of £26.01 million, a price-to-earnings ratio of -279.17 and a beta of 0.10.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- What is the Euro STOXX 50 Index?
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- The Most Important Warren Buffett Stock for Investors: His Own
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Investing in Travel Stocks Benefits
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
